Sport

Array BioPharma Inc. (NASDAQ:ARRY) Price Target Raised to $15.00

Its last month's stock price volatility remained 3.63% which for the week stands at 7.01%. "(ARRY) Rating Reiterated by Jefferies Group LLC" was originally posted by Week Herald and is the sole property of of Week Herald.

Array BioPharma Inc. has a consensus outperform rating from 9 Wall Street analysts, and the number of shares now sold short amount to at least 12.41% of shares outstanding. BidaskClub raised shares of Array BioPharma from a "strong sell" rating to a "sell" rating in a research note on Thursday, June 22nd.

WARNING: "Brokerages Set Array BioPharma Inc". Analysts have placed a $15 price target on Array BioPharma Inc., suggesting a 32.51% gain from recent close. Finally, Cantor Fitzgerald reiterated a buy rating and set a $13.00 price target on shares of Array BioPharma in a research note on Tuesday, July 18th. One analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and seven have given a buy recommendation to the company. (NASDAQ:ARRY) traded down -0.27% in the last session while performance was up 11.29% in the last five days. The volume of KO witnessed a shift from 6.42 million shares, based on a 50-day average, to 9.51 million shares. Array Biopharma has a 12-month low of $2.60 and a 12-month high of $13.40. The firm now has $9.88 price target on the biopharmaceutical company's stock. The share price has moved forward from its 20 days moving average, trading at a distance of 9.02% and stays 23.54% away from its 50 days moving average.

Array BioPharma (NASDAQ:ARRY) last released its earnings results on Wednesday, August 9th. The biopharmaceutical company reported ($0.14) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.18) by $0.04. Its revenue totaled $28.6 million down -14.06% from the previous quarter. Array BioPharma had a negative net margin of 77.44% and a negative return on equity of 1,187.18%. The company's revenue was down 21.8% compared to the same quarter a year ago. ValuEngine upgraded shares of Array BioPharma from a sell rating to a hold rating in a research note on Friday, June 2nd. On average, analysts predict that Array BioPharma will post ($0.99) EPS for the current year. If you are accessing this story on another domain, it was illegally copied and republished in violation of U.S. & global copyright & trademark legislation. If you are accessing this report on another domain, it was copied illegally and reposted in violation of USA and worldwide trademark and copyright laws.

Let's have a look at some of the important valuation ratios of the Array BioPharma Inc.

Point72 Asset Management, L.p. added to its position by buying 1,906,000 shares an increase of 381.2% from 03/31/2017 to 06/30/2017. Marshall Wace North America L.P. now owns 677,109 shares of the biopharmaceutical company's stock valued at $5,417,000 after purchasing an additional 29,543 shares during the period.

As of quarter end First Light Asset Management, LLC had bought 5,297 shares growing its holdings by 0.9%. Its last month's stock price volatility remained 1.75% which for the week approaches 1.52%.

Shares of Array Biopharma (NASDAQ:ARRY) opened at 8.48 on Monday. Teacher Retirement System of Texas now owns 12,737 shares of the biopharmaceutical company's stock worth $107,000 after purchasing an additional 972 shares during the last quarter. Nationwide Fund Advisors increased its stake in Array Biopharma by 40.2% in the third quarter. Venbio Select Advisor LLC grew its ownership by buying 100,000 shares an increase of 25.0%.

The Coca-Cola Company (NYSE:KO) slipped over -0.26% at $45.57, after hitting low of $45.56 in an intra-day trade. Hedge funds and other institutional investors own 87.04% of the company's stock.



Like this

loading...
loading...

Latest


28 September 2017
Boeing, Bombardier dispute could hit United Kingdom jobs
But that dispute is playing out in the World Trade Organization, where the process leading to tariffs is far more circuitous. He told reporters: "I'm not saying it doesn't have an effect on relationships - it does - but not on this negotiation".

28 September 2017
PM Prayut says fugitive Yingluck is in Dubai
Yingluck and her supporters have said she is innocent, and she has called the charges against her politically motivated. Yingluck, who was active on social media, has not commented publicly since disappearing from public view last month.

28 September 2017
Sieving Sells 30485 Shares of NextEra Energy, Inc. (NEE) Stock
Nelson Van Denburg & Campbell Wealth Management Group LLC boosted its holdings in NextEra Energy by 8.9% during the first quarter. BidaskClub cut shares of NextEra Energy from a "strong-buy" rating to a "buy" rating in a research report on Tuesday, June 13th.

28 September 2017
SORL Auto Parts, Inc. (NASDAQ:SORL) Dips Under Moving Averages
Among 26 analysts covering Advance Auto Parts Inc . (NYSE: AAP ) is another stock that is grabbing investors attention these days. It is negative, as 10 investors sold CSU shares while 39 reduced holdings. 39 funds opened positions while 73 raised stakes.

28 September 2017
Rodney Hogg tears into Smith for picking his mates in XI
Australia were whitewashed 5-0 away to South Africa past year and Finch said the mounting losses were not helping with confidence. The Australian captain had also admitted that it indeed becomes hard to motivate the team after such defeats.

28 September 2017
Apple rolling out iOS 11.0.1 update for iPhones and iPads
Some early adopters of the new iPhone 8 and iPhone 8 Plus have reported issues stemming from the built-in earpiece. Meanwhile, the bill of materials cost for the iPhone 8 is $247.51, also around $10 more than the iPhone 7.

28 September 2017
Girl, 11, 'consented' to sex with man
An act can only qualify as rape under French law if there is violence or a threat of violence during a sexual act. The trial, which was to be held Tuesday, was postponed until February 13 to consider a procedural issue.

28 September 2017
Father killed while walking with teenage son in Bronx
Police said the victim's son had been feuding with gang members in recent months and may be a member of a rival gang. Police say they found 39-year-old Pedro Sanchez Almonte, of the Bronx, unconscious with a gunshot wound to the head.

28 September 2017
Ellington Residential Mortgage (NYSE:EARN) Experiences Lighter than Usual Trading Volume
Stocks of ARMOUR Residential REIT (ARR) transacted up 0.64% throughout intraday market trading on early Tue, reaching $26.59. The stock of Ellington Residential Mortgage REIT (NYSE: EARN ) earned "Hold" rating by Deutsche Bank on Thursday, August 6.

28 September 2017
Celgene Corporation (CELG) Insider Terrie Curran Sells 1727 Shares of Stock
The biopharmaceutical company reported $1.82 earnings per share for the quarter, beating the consensus estimate of $1.61 by $0.21. Heading into the stock price potential, Celgene Corporation needs to grow just 8.61% to cross its median price target of $156.